|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.95 SEK | +1.11% |
|
+0.74% | +2.38% |
Xspray Pharma AB (publ) reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported net loss was SEK 55.22 million compared to SEK 51.94 million a year ago. Basic loss per share from continuing operations was SEK 2.48 compared to SEK 2.62 a year ago.
Diluted loss per share from continuing operations was SEK 2.48 compared to SEK 2.62 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.38% | 115M | |
| -1.65% | 104B | |
| +6.75% | 97.47B | |
| +5.71% | 22.25B | |
| -12.60% | 21.68B | |
| -9.70% | 18.2B | |
| -39.98% | 17.02B | |
| -10.17% | 16.36B | |
| +6.12% | 14.39B | |
| +35.47% | 12.37B |
XSPRAY PHARMA AB 
